LONG-TERM OUTCOME OF AN OBSERVATIONAL APPROACH IN PATIENTS WITH<i> NRAS</i>-MUTATED JUVENILE MYELOMONOCYTIC LEUKEMIA AND ABSENCE OF HIGH RISK FEATURES


De Waele J., Hofmans M., Fischer A., Catala A., Dworzak M., Erlacher M., ...More

EJC PAEDIATRIC ONCOLOGY, vol.6, 2025 (ESCI, Scopus)